New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 22, 2013
08:32 EDTSNYGenzyme receives positive CHMP opinion for once-daily, oral AUBAGIO
Genzyme, a Sanofi Company, announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion regarding the approval of once-daily, oral AUBAGIO for the treatment of adult patients with relapsing-remitting multiple sclerosis. The CHMP did not recommend that AUBAGIO receive a new active substance designation. Additional marketing applications for AUBAGIO are under review by regulatory authorities around the world.
News For SNY From The Last 14 Days
Check below for free stories on SNY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 21, 2014
07:11 EDTSNYInternational Society of DNA Vaccines to hold a conference
Subscribe for More Information
July 16, 2014
09:03 EDTSNYSanofi held talks on mature drugs with Abbott, Mylan, PE firms, Reuters says
Sanofi (SNY) has shopped an $8.5B portfolio of mature drugs to Abbott (ABT), Mylan (MYL) and private equity firms, according to Reuters, citing an internal company document circulated by the CGT union. Sanofi is considering whether to sell, carve out or create a joint venture for the portfolio of about 200 drugs, but a Sanofi spokesman said no decision has yet been made, the report noted. Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use